BIOS MEMORY SPV I, LP 13D and 13G filings for Cognition Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-09-23 9:58 pm Purchase | 2025-09-19 | 13D | Cognition Therapeutics, Inc. CGTX | BIOS MEMORY SPV I, LP | 6,059,555 6.900% | 53,555 (+0.89%) | Filing |
| 2023-11-13 5:25 pm Purchase | 2023-11-08 | 13D | Cognition Therapeutics, Inc. CGTX | BIOS MEMORY SPV I, LP | 6,006,000 19.400% | 491,604 (+8.91%) | Filing |
| 2022-12-05 5:27 pm Purchase | 2022-11-15 | 13D | Cognition Therapeutics, Inc. CGTX | BIOS MEMORY SPV I, LP | 5,514,396 23.000% | 1,587,063 (+40.41%) | Filing |
| 2022-02-01 4:03 pm Purchase | 2022-01-31 | 13D | Cognition Therapeutics, Inc. CGTX | BIOS MEMORY SPV I, LP | 3,927,333 17.800% | 3,864 (+0.10%) | Filing |
| 2021-10-25 4:06 pm Purchase | 2021-10-13 | 13D | Cognition Therapeutics, Inc. CGTX | BIOS MEMORY SPV I, LP | 3,923,469 18.300% | 3,923,469 (New Position) | Filing |